Catalyst Wire Dossier Catalyst Wire Dossier

Viltolarsen

viltolarsen · NS Pharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Viltolarsen, covering 2022-10-19 to 2024-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X) [Phase 3]

See pricing